senescence of cultured endothelial cells and pbmc...
TRANSCRIPT
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Senescence of cultured endothelial cells and PBMC from HIV+ patients: implication of ritonavir-boosted PIs
inducing prelamin A. Reversion by statins
Jacqueline Jacqueline CapeauCapeau, Chlo, Chloéé LefLefèèvre, Martine Auclair, Franck vre, Martine Auclair, Franck BoccaraBoccara, Jean, Jean-- Philippe Philippe BastardBastard, Corinne Vigouroux, Martine Caron, Corinne Vigouroux, Martine Caron--DebarleDebarle
INSERM U938, UniversitINSERM U938, Universitéé Pierre et Marie Curie Pierre et Marie Curie FacultFacultéé de Mde Méédecine, site Saintdecine, site Saint--Antoine, Antoine,
HHôpital ôpital Tenon, Paris, FranceTenon, Paris, France
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Introduction
• HIV-infected patients present an increased risk of premature aging including cardio-vascular diseases.
• Protease inhibitors may promote premature cardiovascular disease through endothelial dysfunction either indirectly via dyslipidemia or directly via alterations of endothelial cells.
• The risk of premature cardiovascular events might also result from the accelerated aging imposed by HIV infection and/or ART.
• Vascular endothelial dysfunction is a feature of the human physiological aging process.
• In aged subjects, vascular smooth muscle cells accumulate prelamin A and express senescence markers (CD Ragnauth Circulation 2010).
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
C Navarro Hum. Mol. Gen, 2006
Mature lamin A is present in the lamina meshwork and the nucleoplasm and is maturated form prelamin A
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
• The premature aging syndrome, Hutchinson Gilford progeria, with an early death from cardiovascular diseases, is linked to mutations in lamin A leading to alterations in the prelamin A maturation process
• Some other progeroid syndromes are linked to molecular alterations in the gene encoding ZMPSTE24
• In all cases toxicity is related to accumulation of farnesylated prelamin A
• Some HIV PI are able to inhibit ZMPSTE24 (Coffinier PNAS 2007) resulting in prelamin A accumulation and cell senescence in human fibroblasts (Caron Cell Death Differ 2007)
11 years-old child
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aims of the study
1.1. To study whether a longTo study whether a long--term exposure to RTV or LPV/r term exposure to RTV or LPV/r could induce accelerated senescence in human vascular could induce accelerated senescence in human vascular coronary endothelial cells in primary culture (HCAEC)coronary endothelial cells in primary culture (HCAEC)
2. To search for markers of senescence in PBMC from HIV- infected patients under PI/r
3. To evaluate whether endothelial cells exposure to PI results in increased oxidative stress and inflammation
4. To test whether pravastatin is able to improve the PI adverse effects in endothelial cells
5. To search whether senescence markers are improved in PBMC from HIV-infected patients under statin
6. To test whether antioxidants are able to improve the PI adverse effects in endothelial cells
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aim 1: Long-term exposure of endothelial cells to PI progressively decrease cell proliferation and replication
C Lefèvre ATVB in press, 2010
Cells cultured for up to 30 days in the absence or presence of PIRTV 7.5 M or LPV/r: 10/2 M (purchased from Santa Cruz Biotechnology CA, USA)
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
RTV and LPV/r RTV and LPV/r increaseincrease the expression of the expression of cellcell--cycle cycle arrestarrest proteinsproteins, p21 and p53, and of , p21 and p53, and of senescencesenescence--associatedassociated ßß-- galactosidase galactosidase activityactivity
Aim 1: Long-term exposure to PI trigger endothelial cell senescence
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
AimAim 1: long1: long--termterm exposureexposure to PI to PI induceinduce prelaminprelamin A A accumulation and accumulation and nuclearnuclear dysmorphiesdysmorphies
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aims of the study
1. To study whether a long-term exposure to RTV or LPV/r could induce accelerated senescence in human vascular coronary endothelial cells in primary culture (HCAEC)
2.2. To search for markers of senescence in PBMC from HIVTo search for markers of senescence in PBMC from HIV-- infected patients under PI/rinfected patients under PI/r
3. To evaluate whether endothelial cells exposure to PI results in increased oxidative stress and inflammation
4. To test whether pravastatin is able to improve the PI adverse effects in endothelial cells
5. To search whether senescence markers are improved in PBMC from HIV-infected patients under statin
6. To test whether antioxidants are able to improve the PI adverse effects in endothelial cells
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aim 2: PBMC from HIV-infected patients under PI/r express prelamin A and senescence markers
HIV+ patients HIV+ patients underunder NRTI NRTI withoutwithout PIPI
HIV+ patients HIV+ patients underunder PI/rPI/r
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aims of the study
1. To study whether a long-term exposure to RTV or LPV/r could induce accelerated senescence in human vascular coronary endothelial cells in primary culture (HCAEC)
2. To search for markers of senescence in PBMC from HIV- infected patients under PI/r
3.3. To evaluate whether endothelial cells exposure to PI results To evaluate whether endothelial cells exposure to PI results in increased oxidative stress and inflammationin increased oxidative stress and inflammation
4. To test whether pravastatin is able to improve the PI adverse effects in endothelial cells
5. To search whether senescence markers are improved in PBMC from HIV-infected patients under statin
6. To test whether antioxidants are able to improve the PI adverse effects in endothelial cells
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
AimAim 3: Long3: Long--termterm exposureexposure of of endothelialendothelial cellscells to to PI PI inducesinduces oxidativeoxidative stress and inflammationstress and inflammation
RTV and LPV/r RTV and LPV/r increaseincrease ROS and cytokines/ROS and cytokines/chemokinechemokine production by production by endothelialendothelial cellscells
Oxidative stress Secretion of cytokines and chemokines
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aims of the study
1. To study whether a long-term exposure to RTV or LPV/r could induce accelerated senescence in human vascular coronary endothelial cells in primary culture (HCAEC)
2. To search for markers of senescence in PBMC from HIV- infected patients under PI/r
3. To evaluate whether endothelial cells exposure to PI results in increased oxidative stress and inflammation
4.4. To test whether To test whether pravastatinpravastatin is able to improve the PI adverse is able to improve the PI adverse effects in endothelial cellseffects in endothelial cells
5. To search whether senescence markers are improved in PBMC from HIV-infected patients under statin
6. To test whether antioxidants are able to improve the PI adverse effects in endothelial cells
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
C Navarro Hum Mol Gen 2006
The process of prelamin A maturation into lamin A: effect of statins and farnesyl-transferase inhibitors (FTI)
statinstatin
FT
I
FT
I
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aim 4: Reversion of cell senescence in endothelial cells by a treatment with statin or FTI
C Lefevre ATVB, in press 2010
Statin and FTI decrease the level of farnesylated prelamin A(Pravastatin was purchased from Sigma-Aldrich, France)
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aim 4: Reversion of oxidative stress and inflammation in endothelial cells by a treatment with statin or FTI
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aims of the study
1. To study whether a long-term exposure to RTV or LPV/r could induce accelerated senescence in human vascular coronary endothelial cells in primary culture (HCAEC)
2. To search for markers of senescence in PBMC from HIV- infected patients under PI/r
3. To evaluate whether endothelial cells exposure to PI results in increased oxidative stress and inflammation
4. To test whether pravastatin is able to improve the PI adverse effects in endothelial cells
5.5. To search whether senescence markers are improved in To search whether senescence markers are improved in PBMC from HIVPBMC from HIV--infected patients under infected patients under statinstatin
6. To test whether antioxidants are able to improve the PI adverse effects in endothelial cells
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aim 5: Decreased expression of senescence markers in PBMC from HIV-infected patients under PI/r and a statin
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aims of the study
1. To study whether a long-term exposure to RTV or LPV/r could induce accelerated senescence in human vascular coronary endothelial cells in primary culture (HCAEC)
2. To search for markers of senescence in PBMC from HIV- infected patients under PI/r
3. To evaluate whether endothelial cells exposure to PI results in increased oxidative stress and inflammation
4. To test whether pravastatin is able to improve the PI adverse effects in endothelial cells
5. To search whether senescence markers are improved in PBMC from HIV-infected patients under statin
6.6. To test whether antioxidants are able to improve the PI To test whether antioxidants are able to improve the PI adverse effects in endothelial cellsadverse effects in endothelial cells
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aim 6: Reversion of oxidative stress in endothelial cells by a treatment with antioxidants
The impact of two antioxidants, N-acetyl cysteine and Mn-TBAP was evaluatedPrelamin A accumulation was unaffected by antioxidants
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Aim 6: Reversion of senescence in endothelial cells by a treatment with antioxidants
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Hypothetical mechanisms of RTV-boosted PI toxicityin endothelial cells
DrugsDrugs
Inhibition of ZMP‐STE24Inhibition of ZMP‐STE24
Accumulation of farnesylated
prelamin
AAccumulation of farnesylated
prelamin
A
Increased
ROSIncreased
ROS
Activation of NFkBActivation of NFkB
Increased
IL6, IL8, MCP‐1Increased
IL6, IL8, MCP‐1 Systemic
low
grade inflammationSystemic
low
grade inflammation
Cellular senescenceCellular senescence
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Hypothetical mechanisms of RTV-boosted PI toxicityin endothelial cells: beneficial effect of statins
DrugsDrugs
Inhibition of ZMP‐STE24Inhibition of ZMP‐STE24
Accumulation of farnesylated
prelamin
AAccumulation of farnesylated
prelamin
A
Increased
ROSIncreased
ROS
Activation of NFkBActivation of NFkB
Increased
IL6, IL8, MCP‐1Increased
IL6, IL8, MCP‐1 Systemic
low
grade inflammationSystemic
low
grade inflammation
Cellular senescenceCellular senescence
StatinsStatins
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Hypothetical mechanisms of RTV-boosted PI toxicityin endothelial cells: beneficial effect of antioxidants
DrugsDrugs
Inhibition of ZMP‐STE24Inhibition of ZMP‐STE24
Accumulation of farnesylated
prelamin
AAccumulation of farnesylated
prelamin
A
Increased
ROSIncreased
ROS
Activation of NFkBActivation of NFkB
Increased
IL6, IL8, MCP‐1Increased
IL6, IL8, MCP‐1 Systemic
low
grade inflammationSystemic
low
grade inflammation
Cellular senescenceCellular senescenceAnti‐oxidantsAnti‐oxidants
Presented at the 1st Int. workshop on HIV & Aging, 4 – 5 Oct. 2010, Baltimore, USA
Conclusion
• RTV and RTV-boosted LPV trigger premature senescence, oxidative stress and inflammation in human endothelial cells by a mechanism involving prelamin A accumulation • Senescence markers and prelamin A are also present in PBMC from HIV-infected patients under PI/r• This suggests that PI/r might participate to the early development of cardio-vascular disease in HIV-infected patients through prelamin A accumulation• Statins were associated with improved senescence in endothelial cells and patients’ PBMC• The ability of statins to improve PI-induced vascular senescence could be beneficial in these patients